Business
Currency:USD
2025/Q3
Stock NameRevenueRatio
United States (US) Pharmaceutical87.11B91.41%
International3.86B4.05%
Medical-Surgical Solutions2.95B3.09%
Prescription Technology Solutions1.37B1.44%
Corporate4M0.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States294.82B95.43%
International14.13B4.57%